IRCT20200503047281N1尚未招募早期 1 期
Evaluation of Convalescent Plasma Therapy for COVID-19 Patients
Yazd University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 早期 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 60 years（—）
- 性别
- All
入选标准
- •age between 20 to 60 years old
排除标准
- •People with a history of other immune, genetic or infectious diseases other than corona
- •Individual suspended but negative for clinical standard covid-19 test
研究者
相似试验
招募中
2 期
Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patientsIRCT20200406046968N2Tabriz University of Medical Sciences30
已完成
2 期
Effect of convalescent plasma in COVID-19 patientsCTRI/2020/04/024706Institute of Liver and Biliary Sciences29
招募中
不适用
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical TrialCOVID-19.Coronavirus infection, unspecifiedB34.2IRCT20181104041551N1Mazandaran University of Medical Sciences30
已完成
3 期
Effect of convalescent plasma in COVID-19 patientsCTRI/2020/06/025803Institute of Liver and Biliary Sciences400
已完成
2 期
Efficacy of Combined Convalescent Plasma Therapy with Oral RNA-dependent RNA Polymerase Inhibitor versus Monoclonal Neutralizing Antibody Therapy among Mild to Moderate COVID-19 in Outpatients: Multicenter, Non-inferiority, Open-label Randomized Controlled TrialMild to moderate COVID-19 (non-severe COVID-19)COVID-19, SARS-CoV-2, favipiravir, sotrovimab, convalescent plasma therapy, monoclonal neutralizing antibodyTCTR20220319002Chulabhorn Royal Academy136